Mellanox Technologies Ltd major shareholder Mary Cranston, Bought $15053 in Stock; Last Week Baxter International Inc. (BAX) Coverage

Mellanox Technologies Ltd’s major shareholder, Mary Cranston, obtained 223 shares of stock in the public company. The documented cost for each share was $67.5, for full transaction worth of $15,053 USD. Mary Cranston today has rights to 223 shares which are around 10%+ of the California-Company’s market cap.

Among 18 analysts covering Baxter International (NYSE:BAX), 11 have Buy rating, 0 Sell and 7 Hold. Therefore 61% are positive. Baxter International had 49 analyst reports since July 30, 2015 according to SRatingsIntel. The stock has “Buy” rating by Bank of America on Tuesday, January 2. The rating was upgraded by Piper Jaffray to “Overweight” on Thursday, April 14. The rating was maintained by Cowen & Co with “Hold” on Friday, October 13. The company was maintained on Wednesday, November 22 by RBC Capital Markets. The stock of Baxter International Inc. (NYSE:BAX) earned “Hold” rating by RBC Capital Markets on Monday, July 10. BMO Capital Markets upgraded the stock to “Outperform” rating in Tuesday, July 11 report. The rating was maintained by Morgan Stanley with “Equal-Weight” on Tuesday, July 25. The firm has “Sector Perform” rating by RBC Capital Markets given on Wednesday, October 26. RBC Capital Markets maintained the shares of BAX in report on Monday, October 2 with “Hold” rating. The stock has “Hold” rating by RBC Capital Markets on Friday, September 1. See Baxter International Inc. (NYSE:BAX) latest ratings:

03/01/2018 Broker: Evercore Rating: Outperform New Target: $71 Initiates Coverage On
03/01/2018 Broker: Raymond James Old Rating: Market Perform New Rating: Outperform Upgrade
02/01/2018 Broker: Bank of America Old Rating: Neutral New Rating: Buy Upgrade
02/01/2018 Broker: JP Morgan Old Rating: Neutral New Rating: Overweight Upgrade
12/12/2017 Broker: BMO Capital Markets Rating: Buy New Target: $74.0 Maintain
01/12/2017 Broker: Raymond James Rating: Hold
22/11/2017 Broker: RBC Capital Markets Rating: Hold New Target: $66.0 Maintain
13/11/2017 Broker: BMO Capital Markets Rating: Buy New Target: $70.0 Maintain
26/10/2017 Broker: Barclays Capital Rating: Overweight Old Target: $70 New Target: $73 Maintain
26/10/2017 Broker: Morgan Stanley Rating: Equal-Weight Old Target: $59 New Target: $62 Maintain

Investors sentiment increased to 0.95 in Q3 2017. Its up 0.02, from 0.93 in 2017Q2. It increased, as 23 investors sold Mellanox Technologies, Ltd. shares while 40 reduced holdings. 17 funds opened positions while 43 raised stakes. 29.80 million shares or 0.19% more from 29.75 million shares in 2017Q2 were reported. Ion Asset Limited reported 1.24 million shares. Goldman Sachs has 547,469 shares for 0.01% of their portfolio. Credit Suisse Ag holds 0% or 20,102 shares. Moreover, Bluefin Trading has 0.11% invested in Mellanox Technologies, Ltd. (NASDAQ:MLNX) for 20,172 shares. Benjamin F Edwards Company Inc holds 0% of its portfolio in Mellanox Technologies, Ltd. (NASDAQ:MLNX) for 350 shares. Bancorp Hapoalim Bm stated it has 0.33% of its portfolio in Mellanox Technologies, Ltd. (NASDAQ:MLNX). Herald Invest Mgmt Limited has invested 3.08% of its portfolio in Mellanox Technologies, Ltd. (NASDAQ:MLNX). Canada Pension Plan Inv Board reported 0.01% of its portfolio in Mellanox Technologies, Ltd. (NASDAQ:MLNX). Group One Trading Limited Partnership reported 0.02% in Mellanox Technologies, Ltd. (NASDAQ:MLNX). Guggenheim Cap Limited Liability Co reported 0% in Mellanox Technologies, Ltd. (NASDAQ:MLNX). 1.19M were accumulated by Clal Insurance Enter Hldg. Reilly Fincl Advisors Limited Liability Co has invested 0% in Mellanox Technologies, Ltd. (NASDAQ:MLNX). Credit Agricole S A stated it has 0% of its portfolio in Mellanox Technologies, Ltd. (NASDAQ:MLNX). Jpmorgan Chase And reported 24,285 shares stake. Bamco Inc has 0.03% invested in Mellanox Technologies, Ltd. (NASDAQ:MLNX).

Among 19 analysts covering Mellanox Tech (NASDAQ:MLNX), 10 have Buy rating, 1 Sell and 8 Hold. Therefore 53% are positive. Mellanox Tech has $80 highest and $38.0 lowest target. $60.75’s average target is -7.81% below currents $65.9 stock price. Mellanox Tech had 47 analyst reports since July 23, 2015 according to SRatingsIntel. The stock of Mellanox Technologies, Ltd. (NASDAQ:MLNX) has “Buy” rating given on Friday, December 1 by Longbow. The stock of Mellanox Technologies, Ltd. (NASDAQ:MLNX) earned “Overweight” rating by JP Morgan on Thursday, February 25. The rating was maintained by Susquehanna on Friday, January 19 with “Buy”. The firm has “Sell” rating by Jefferies given on Monday, July 10. The stock of Mellanox Technologies, Ltd. (NASDAQ:MLNX) has “Buy” rating given on Tuesday, August 22 by Stifel Nicolaus. The firm has “Outperform” rating by Credit Suisse given on Monday, January 11. On Thursday, January 28 the stock rating was maintained by Topeka Capital Markets with “Hold”. The firm earned “Buy” rating on Thursday, January 18 by Stifel Nicolaus. Summit Redstone Partners initiated the shares of MLNX in report on Tuesday, June 21 with “Buy” rating. The firm has “Neutral” rating given on Thursday, October 26 by JP Morgan.

Mellanox Technologies, Ltd., a fabless semiconductor company, designs, makes, and sells interconnect products and solutions. The company has market cap of $3.36 billion. The Company’s products facilitate data transmission between servers, storage systems, communications infrastructure equipment, and other embedded systems. It currently has negative earnings. The firm offers InfiniBand solutions, including switch and gateway integrated circuits , adapter cards, cables, modules, and software, as well as switch, gateway, and long-haul systems; Ethernet solution for use in enterprise data center, high-performance computing, embedded environments, hyperscale Web 2.0, and cloud data centers; and Ethernet adapters.

Analysts await Mellanox Technologies, Ltd. (NASDAQ:MLNX) to report earnings on February, 7. They expect $0.35 EPS, down 28.57% or $0.14 from last year’s $0.49 per share. MLNX’s profit will be $17.82M for 47.07 P/E if the $0.35 EPS becomes a reality. After $0.35 actual EPS reported by Mellanox Technologies, Ltd. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

The stock decreased 0.68% or $0.45 during the last trading session, reaching $65.9. About 963,530 shares traded or 25.09% up from the average. Mellanox Technologies, Ltd. (NASDAQ:MLNX) has risen 12.09% since January 24, 2017 and is uptrending. It has underperformed by 4.61% the S&P500.

Since July 31, 2017, it had 0 buys, and 7 selling transactions for $4.23 million activity. On Friday, September 8 the insider Sultzbaugh Marc sold $231,790. Another trade for 12,590 shares valued at $827,730 was sold by Shulman Yakov (Jacob). Kagan Michael had sold 2,500 shares worth $116,388. Another trade for 5,500 shares valued at $356,815 was made by Dorchak Glenda on Thursday, January 4. Another trade for 50,000 shares valued at $2.36M was made by Cohen Shai on Monday, July 31.

Baxter International Inc. provides a portfolio of renal and hospital products. The company has market cap of $38.23 billion. The firm operates through two divisions, Hospital Products and Renal. It has a 37.56 P/E ratio. The Hospital Products segment makes intravenous solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics, and biosurgery products.

Since August 17, 2017, it had 0 insider buys, and 4 insider sales for $2.16 million activity. Another trade for 4,020 shares valued at $247,672 was made by Shapazian Carole J on Thursday, August 24. Shares for $555,538 were sold by STALLKAMP THOMAS T. Accogli Giuseppe also sold $772,363 worth of Baxter International Inc. (NYSE:BAX) shares. Another trade for 9,440 shares valued at $583,014 was sold by FORSYTH JOHN D.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: